-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Guardant Health, Raises Price Target to $200

Benzinga·07/31/2026 17:59:59
Listen to the news
Mizuho analyst Anthony Petrone maintains Guardant Health (NASDAQ:GH) with a Outperform and raises the price target from $175 to $200.